Denton GW - Search Results

1

An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.

Durrant LG, Denton GW, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA. Durrant LG, et al. Among authors: denton gw. Int J Cancer. 1992 Mar 12;50(5):811-6. doi: 10.1002/ijc.2910500525. Int J Cancer. 1992. PMID: 1544714

2

Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.

Robins RA, Denton GW, Hardcastle JD, Austin EB, Baldwin RW, Durrant LG. Robins RA, et al. Among authors: denton gw. Cancer Res. 1991 Oct 1;51(19):5425-9. Cancer Res. 1991. PMID: 1913661 Clinical Trial.

3

Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7.

Durrant LG, Buckley TJ, Denton GW, Hardcastle JD, Sewell HF, Robins RA. Durrant LG, et al. Among authors: denton gw. Cancer Res. 1994 Sep 15;54(18):4837-40. Cancer Res. 1994. PMID: 8069847

4

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.

Denton GW, Durrant LG, Hardcastle JD, Austin EB, Sewell HF, Robins RA. Denton GW, et al. Int J Cancer. 1994 Apr 1;57(1):10-4. doi: 10.1002/ijc.2910570103. Int J Cancer. 1994. PMID: 8150527 Clinical Trial.

5

Immunization with human monoclonal antiidiotypic antibody in colorectal cancer.

Durrant LG, Denton GW, Robins RA. Durrant LG, et al. Among authors: denton gw. Ann N Y Acad Sci. 1993 Aug 12;690:334-6. doi: 10.1111/j.1749-6632.1993.tb44022.x. Ann N Y Acad Sci. 1993. PMID: 8368747 Clinical Trial. No abstract available.

6

Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.

Byers VS, Austin EB, Clegg JA, Denton G, Gunn B, Hooi D, Hudecz F, Price MR, Baldwin RW. Byers VS, et al. J Clin Immunol. 1993 Nov;13(6):406-14. doi: 10.1007/BF00920016. J Clin Immunol. 1993. PMID: 7507127

7

Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.

Perkins AC, Vincent RM, Wastie ML, Denton GW, Amar S, Hardcastle JD. Perkins AC, et al. Among authors: denton gw. Nucl Med Commun. 1994 Dec;15(12):981-90. doi: 10.1097/00006231-199412000-00010. Nucl Med Commun. 1994. PMID: 7715898

8

Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.

Smyth JF, Hardcastle JD, Denton G, Alderson D, Grace RH, Mansi JL, Yosef HM, Nordle O, Lauri H, Wählby S. Smyth JF, et al. Ann Oncol. 1995 Nov;6(9):948-9. doi: 10.1093/oxfordjournals.annonc.a059365. Ann Oncol. 1995. PMID: 8624301 Free article. Clinical Trial. No abstract available.

9

Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.

Denton G, Sekowski M, Price MR. Denton G, et al. Cancer Lett. 1993 Jul 16;70(3):143-50. doi: 10.1016/0304-3835(93)90224-w. Cancer Lett. 1993. PMID: 7689035

10

Production and characterization of an anti-(MUC1 mucin) recombinant diabody.

Denton G, Brady K, Lo BK, Murray A, Graves CR, Hughes OD, Tendler SJ, Laughton CA, Price MR. Denton G, et al. Cancer Immunol Immunother. 1999 Apr;48(1):29-38. doi: 10.1007/s002620050545. Cancer Immunol Immunother. 1999. PMID: 10235486 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters